Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Reprod Sci ; 28(2): 371-380, 2021 02.
Artículo en Inglés | MEDLINE | ID: mdl-32780358

RESUMEN

Spermatogenesis process is sensitive to heat stress because the testicular temperature is 2 to 4 °C lower than the core body temperature. The current study aimed to investigate the effects of iron oxide nanoparticles containing curcumin on spermatogenesis in mice induced by long-term scrotal hyperthermia. In this experimental study, 18 mice were equally divided into the following three groups: control, scrotal hyperthermia, and scrotal hyperthermia + curcumin-loaded iron particles (NPs) (240 µL) (mice were treated for 20 days). Hyperthermia was induced by exposure to the temperature of 43 °C for 20 min every other day for 5 weeks. Afterward, the animals were euthanized; sperm samples were collected for sperm parameters analysis, and testis samples were taken for histopathology experiments, evaluation of serum testosterone level, and RNA extraction in order to examine the expression of c-kit, STRA8 and PCNA genes. Our study showed that curcumin-loaded iron particles could notably increase the volume of testis, length of seminiferous tubules, sperm parameters, and stereological parameters (i.e., spermatogonia, primary spermatocyte, round spermatid, and Leydig cells) thereby increasing serum testosterone level; in addition, TUNEL-positive cells showed a significant decrease in curcumin-loaded iron particle group. Thus, based on the obtained results, the expression of c-kit, STRA8, and PCNA genes was significantly increased in treatment groups by curcumin-loaded iron particles compared with scrotal hyperthermia-induced mice. In conclusion, curcumin-loaded iron particles can be considered an alternative treatment for improving the spermatogenesis process in scrotal hyperthermia-induced mice.


Asunto(s)
Azoospermia/tratamiento farmacológico , Curcumina/farmacología , Portadores de Fármacos , Fármacos para la Fertilidad Masculina/farmacología , Nanopartículas Magnéticas de Óxido de Hierro/química , Espermatogénesis/efectos de los fármacos , Espermatozoides/efectos de los fármacos , Testículo/efectos de los fármacos , Proteínas Adaptadoras Transductoras de Señales/genética , Proteínas Adaptadoras Transductoras de Señales/metabolismo , Animales , Azoospermia/sangre , Azoospermia/etiología , Azoospermia/patología , Biomarcadores/sangre , Curcumina/química , Modelos Animales de Enfermedad , Composición de Medicamentos , Fármacos para la Fertilidad Masculina/química , Hipertermia Inducida , Masculino , Ratones , Antígeno Nuclear de Célula en Proliferación/genética , Antígeno Nuclear de Célula en Proliferación/metabolismo , Proteínas Proto-Oncogénicas c-kit/genética , Proteínas Proto-Oncogénicas c-kit/metabolismo , Espermatozoides/metabolismo , Espermatozoides/patología , Testículo/metabolismo , Testículo/patología , Testículo/fisiopatología , Testosterona/sangre , Factores de Tiempo
2.
Andrologia ; 52(3): e13507, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-31943308

RESUMEN

Our aim was to explore the existence of a possible relationship of sperm motility with serum 25-hydroxyvitamin D3 (25-OH VD) levels and with ischaemia-modified albumin (IMA) levels in infertile Turkish men. A total of 30 men with nonobstructive azoospermia (no spermatozoa in ejaculate), 30 men with oligospermia (total progressive motile sperm count (TPMSC) <15 × 106 /ml) and 33 fertile men with normospermia (with at least one child, as the control group) were enrolled in the study. The mean 25-OH VD levels for groups 1, 2 and 3 were 9.31 ± 6.46, 19.71 ± 12.80 and 30.52 ± 12.49 respectively (p < .05). There was a statistically significant difference in serum IMA levels among the groups (479.32 ± 307.56 vs. 296.37 ± 127.27 vs. 150.04 ± 81.05, respectively; p < .05). A positive correlation between serum 25-OH VD levels and TPMSC, and a negative correlation between TPMSC and serum IMA levels were determined. Infertile men had lower serum 25-OH VD and higher IMA levels than fertile men, with a positive correlation between serum 25-OH VD levels and TPMSC, and a negative correlation between TPMSC and serum IMA levels. Vitamin D supplementation may increase the sperm motility.


Asunto(s)
Azoospermia/sangre , Calcifediol/sangre , Oligospermia/sangre , Adulto , Azoospermia/tratamiento farmacológico , Biomarcadores/sangre , Calcifediol/administración & dosificación , Estudios Transversales , Humanos , Masculino , Oligospermia/tratamiento farmacológico , Albúmina Sérica Humana , Recuento de Espermatozoides , Motilidad Espermática/efectos de los fármacos , Turquía
3.
Andrology ; 5(4): 704-710, 2017 07.
Artículo en Inglés | MEDLINE | ID: mdl-28440964

RESUMEN

The methylenetetrahydrofolate reductase (MTHFR) gene codes a crucial enzyme which involve in folate metabolism. The effect of MTHFR gene polymorphisms on male fertility status is uncertain and controversial. We evaluated the effect of B vitamin family intake on total homocysteine content and semen parameters of men with MTHFR gene polymorphisms. MTHFR genotypes frequency and serum total homocysteine concentration were measured among 280 men with impaired spermatogenesis (asthenospermia, oligospermia, severe oligospermia and azoospermia) and 85 control participants. B vitamin family dietary intakes were assessed using a semi-quantitative food-frequency questionnaire. In addition, concentrations of vitamins B9 and B12 were evaluated in serum samples of some participants (n = 60). We observed significantly higher frequency of TC or TT genotypes in C677T polymorphism among oligospermic, severe oligospermic and azoospermic men. CC genotype of A1298C polymorphism was significantly higher only in azoospermic men. Also, we observed critical effect of vitamin B9 and B12 intake on decreasing of total homocysteine and improving of semen parameters among the men with T allele of MTHFR C677T polymorphism. Our investigation showed that sufficient consumption of vitamins B9 and B12 influences sperm parameters of men with different MTHFR polymorphisms, especially genotypes with T allele.


Asunto(s)
Azoospermia/tratamiento farmacológico , Suplementos Dietéticos , Fertilidad/efectos de los fármacos , Ácido Fólico/administración & dosificación , Homocisteína/sangre , Metilenotetrahidrofolato Reductasa (NADPH2)/genética , Oligospermia/tratamiento farmacológico , Polimorfismo Genético , Vitamina B 12/administración & dosificación , Adulto , Azoospermia/sangre , Azoospermia/genética , Azoospermia/fisiopatología , Estudios de Casos y Controles , Fertilidad/genética , Ácido Fólico/metabolismo , Frecuencia de los Genes , Heterocigoto , Homocigoto , Humanos , Irán , Masculino , Metilenotetrahidrofolato Reductasa (NADPH2)/metabolismo , Oligospermia/sangre , Oligospermia/genética , Oligospermia/fisiopatología , Fenotipo , Índice de Severidad de la Enfermedad , Vitamina B 12/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA